» Articles » PMID: 37713088

Salidroside Promotes Healthy Longevity by Interfering with HSP90 Activity

Overview
Journal Geroscience
Specialty Geriatrics
Date 2023 Sep 15
PMID 37713088
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is a risk factor for human health and quality of life. Screening and development of novel supplements and medications to combat aging and delay the incidence of age-related diseases are of great significance. In this study, salidroside (SA), a primary natural small molecule from Rhodiola rosea, was investigated regarding its effects on life and healthspan and the underlying molecular mechanism(s) of anti-aging and antioxidation. Our results showed that SA effectively prolonged lifespan and exhibited anti-aging and antioxidative properties. Computer-assisted methods, label-free interaction analysis, and in vitro assays showed that SA directly bound heat shock protein 90 (HSP90). Furthermore, SA significantly inhibited the ATPase activity of HSP90, affecting the interaction between HSP90 and its interacting proteins and the expression of downstream genes to regulate lifespan and the oxidative stress response. Our findings provided new insights into the pharmacological properties of SA across multiple species and its potential as an anti-aging drug.

References
1.
Davenport J, Manjarrez J, Peterson L, Krumm B, Blagg B, Matts R . Gambogic acid, a natural product inhibitor of Hsp90. J Nat Prod. 2011; 74(5):1085-92. PMC: 3103600. DOI: 10.1021/np200029q. View

2.
Austad S, Fischer K . Sex Differences in Lifespan. Cell Metab. 2016; 23(6):1022-1033. PMC: 4932837. DOI: 10.1016/j.cmet.2016.05.019. View

3.
Chen C, Song J, Chen M, Li Z, Tong X, Hu H . Rhodiola rosea extends lifespan and improves stress tolerance in silkworm, Bombyx mori. Biogerontology. 2015; 17(2):373-81. DOI: 10.1007/s10522-015-9622-8. View

4.
Bottino C, Peserico A, Simone C, Caretti G . SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways. Cancers (Basel). 2020; 12(1). PMC: 7017119. DOI: 10.3390/cancers12010142. View

5.
Fuhrmann-Stroissnigg H, Niedernhofer L, Robbins P . Hsp90 inhibitors as senolytic drugs to extend healthy aging. Cell Cycle. 2018; 17(9):1048-1055. PMC: 6110594. DOI: 10.1080/15384101.2018.1475828. View